Patents by Inventor Hakan Schulz

Hakan Schulz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUMARATE SALT OF 5-((5-METHYL-2-((3,4,5-TRIMETHYLPHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)-BENZO[D]OXAZOL-2(3H)-ONE
    Publication number: 20210198248
    Abstract: A fumarate salt, in particular the hemi-fumarate salt, of 5-((5-methyl-2-((3,4,5-trimethylphenyl)amino)pyrimidin-4-yl)amino)-benzo[d]oxazol-2(3H)-one (Compound (I), compositions comprising such a salt, and processes for the manufacture of such a salt, in particular Compound (I) hemi-fumarate salt are described. The salt is useful for the treatment of conditions such as asthma and COPD, involving modulation of the JAK pathway or inhibition of JAK kinases particularly JAK1.
    Type: Application
    Filed: May 20, 2019
    Publication date: July 1, 2021
    Inventors: Håkan SCHULZ, Reed Warren SMITH, JR.
  • Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
    Patent number: 8673907
    Abstract: The present invention concerns hydrochloric acid, hydrobromic acid and maleic acid salts of methyl (3-{[[3-(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)propyl](3-morpholin-4-ylpropyl)amino]methyl}phenyl)acetate, compositions comprising them and their use in therapy.
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: March 18, 2014
    Assignees: AstraZeneca AB, Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Thomas McInally, Håkan Schulz
  • PHARMACEUTICALLY ACCEPTABLE SALTS OF METHYL (3-{ [[3-(6- AMINO- 2-BUTOXY-8-OXO-7, 8-DIHYDRO-9H-PURIN-9-YL) PROPYL] (3- MORPHOLIN-4-YLPROPYL) AMINO] METHYL }PHENYL) ACETATE AND THEIR USE IN THERAPY
    Publication number: 20110294802
    Abstract: The present invention concerns hydrochloric acid, hydrobromic acid and maleic acid salts of methyl (3-{[[3-(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)propyl](3-morpholin-4-ylpropyl)amino]methyl}phenyl)acetate, compositions comprising them and their use in therapy.
    Type: Application
    Filed: December 16, 2008
    Publication date: December 1, 2011
    Inventors: Thomas Mcinally, Håkan Schulz
  • Novel Tricyclic Spiropiperidine Compounds, Their Synthesis and Their Uses as Modulators of Chemokine Receptor Activity
    Publication number: 20090176815
    Abstract: Compounds of formula (I) wherein R1, R3, R4, R5, R6, R7, and R10 are as defined in the specification, are described. The present invention also relates to pharmaceutical composition comprising said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. Beside, the invention relates to salts and polymorphic forms of the new compounds as well as the preparation thereof.
    Type: Application
    Filed: January 16, 2009
    Publication date: July 9, 2009
    Inventors: Tomas Eriksson, Martin Hemmerling, Bo-Goran Josefsson, Svetlana Ivanova, Marguerite Mensonides-Harsema, John Mo, John Pavey, Austen Pimm, James Reuberson, Hakan Schulz, Per Strandberg
  • Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory Diseases
    Publication number: 20080194632
    Abstract: The invention provides compounds of formula wherein m, R1, R2 and R3 are as defined in the specification, salts and polymorphic forms thereof, processes for the preparation of the compounds, salts and polymorphs, pharmaceutical compositions containing these compounds, salts and/or polymorphic forms and their use in therapy.
    Type: Application
    Filed: July 31, 2006
    Publication date: August 14, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Julien Giovannini, Bo-Goran Josefsson, Marguerite Mensonides-Harsema, Hakan Schulz
  • Novel Compounds 243
    Publication number: 20080167332
    Abstract: Compounds of formula (I) wherein R1, R3, R4, R5, R6, R7, and R10 are as defined in the specification, are described. The present invention also relates to pharmaceutical composition comprising said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. Beside, the invention relates to salts and polymorphic forms of the new compounds as well as the preparation thereof.
    Type: Application
    Filed: July 18, 2007
    Publication date: July 10, 2008
    Inventors: Scott Gibson, Barry Elkins, Mike Rogers, Ian Hassall, Hong Gu, Zhenyu Wang, Vinod Kumar, Synthana Suresh Kumar, Santosh Kavitake, Sidda Lingesha, Eric Merifield, David Ennis, John Pavey, Austen Pimm, James Reuberson, Bo-Goran Josefsson, Martin Hemmerling, Svetlana Ivanova, Marguerite Mensonides-Harsema, Hakan Schulz, John Mo, Tomas Eriksson, Per Strandberg